JLABS the start up incubator

JlabsThe healthcare and pharma arena has a proper necessity of innovation. Most of the big companies spend every year more the 10% of the their income in R&D or adopt a different approach, the acquisition of innovative little companies or start-up.

Johnson & Johnson tries the third way: invest into a start-up incubator to accelerate the innovative solutions from design to ‘go to market’, this is JLABS.
I personally think that this is a winning point: J&J has not only the necessary funds to invest and to put together the necessary facilities to facilitate the scientists/start-uppers, but J&J as all the pharma/healthcare companies knows very well the regulatory and registration mechanisms in this complex market and that’s why they put together an ecosystem to help te new-co on these tasks.

Below you can find some of the most interesting research companies included by the JLABS program: consider also the cross-pollination process which could be a natural consequence of having all people working in the same place who could have same problem / solutions to share.

Analytical 4 Life
JLABS @ Toronto
Analytics 4 Life (A4L) has developed a proprietary signal processing and machine intelligence platform, Agilytics™, to produce machine-learned solutions for the purposes of detecting disease. Agilytics™ works by mathematically deciphering critical patterns and relationships from billions of captured data points paired with clinical results.

JLABS @ Toronto
Mediphage Bioceuticals (MB) is a School of Pharmacy, University of Waterloo research group and spin-off biotechnology firm that focuses on the manipulation of bacteriophages to develop new therapeutics and cosmeceuticals.

JLABS @ Toronto
Vasomune Therapeutics is a Toronto-based biotechnology company developing first in class therapies to target a range of acute vascular complications.

JLABS @ Toronto
Densitas Inc. is an ISO 13485-certified medical technology company that develops data-driven solutions for clinical decision making.

JLABS @ Toronto
About us
DoseBiome is focused on innovative oral microbiome research that improves the microbial ecosystem in the mouth by preventing diseases such as dental caries and periodontal conditions.